|
|||||
|
|
Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study |
|
| Authors: | Pro Barbara Advani Ranjana Brice Pauline Bartlett Nancy L Rosenblatt Joseph D Illidge Tim Matous Jeffrey Ramchandren Radhakrishnan Fanale Michelle Connors Joseph M Yang Yin Sievers Eric L Kennedy Dana A Shustov Andrei |
| Affiliation: | Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111-2497, USA. Barbara.pro@fccc.edu |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |